➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
McKesson
McKinsey
Harvard Business School
Boehringer Ingelheim

Last Updated: January 22, 2021

DrugPatentWatch Database Preview

Litigation Details for Genzyme Corporation v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2016)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Genzyme Corporation v. Zydus Pharmaceuticals (USA) Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Genzyme Corporation v. Zydus Pharmaceuticals (USA) Inc. (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2018-08-21 109 Judgment ofU.S. Patent No. 6,987,102 ("the '102 patent") and claims 8 and 19 ofU.S. Patent No., …claim 8 of the '1 02 patent and claims 8 and 19 of the '590 patent, to the extent that those…claim 8 of the '1 02 patent and claims 8 and 19 ofthe '590 patent, and the use, sale, or offer…claim 8 of the '1 02 patent and claims 8 and 19 of the '590 patent, and because those claims…, 7,897,590 ("the '590 patent") are invalid due to derivation (or anticipation), obviousness External link to document
2018-08-21 111 Patent/Trademark Report to Commissioner of Patents Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,897,590 B2 ;US 6,987,102 B2. (nmg)…2016 21 August 2018 1:16-cv-00540 830 Patent None District Court, D. Delaware External link to document
2016-06-29 4 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,897,590 B2; US 6,987,102 B2;. (sar…2016 21 August 2018 1:16-cv-00540 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Baxter
Merck
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.